Uniprot AC Entrez ID Gene Name Disease Cell Type PTM Type State Position PMID O43175 26227 PHGDH PGDH3 Brain lower grade glioma Acetylation N A2 O43175 26227 PHGDH PGDH3 Kidney renal clear cell carcinoma Acetylation N A2 O43175 26227 PHGDH PGDH3 Melanoma Acetylation N A2 O43175 26227 PHGDH PGDH3 Brain lower grade glioma Methylation N R7 O43175 26227 PHGDH PGDH3 Kidney renal clear cell carcinoma Methylation N R7 O43175 26227 PHGDH PGDH3 Brain lower grade glioma Ubiquitination N K8 O43175 26227 PHGDH PGDH3 Kidney renal clear cell carcinoma Ubiquitination N K8 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency SUMOylation N K21 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K21 O43175 26227 PHGDH PGDH3 Skin cutaneous melanoma Phosphorylation N S55 O43175 26227 PHGDH PGDH3 Skin cutaneous melanoma Phosphorylation N T57 O43175 26227 PHGDH PGDH3 Skin cutaneous melanoma Ubiquitination N K58 O43175 26227 PHGDH PGDH3 Prostate adenocarcinoma Phosphorylation N T60 O43175 26227 PHGDH PGDH3 Skin cutaneous melanoma Phosphorylation N T60 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Ubiquitination N K69 O43175 26227 PHGDH PGDH3 Prostate adenocarcinoma Ubiquitination N K69 O43175 26227 PHGDH PGDH3 Skin cutaneous melanoma Ubiquitination N K69 O43175 26227 PHGDH PGDH3 Brain lower grade glioma Methylation N R75 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Methylation N R75 O43175 26227 PHGDH PGDH3 Brain lower grade glioma Phosphorylation N T78 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Phosphorylation N T78 O43175 26227 PHGDH PGDH3 Bladder urothelial carcinoma Phosphorylation N T89 O43175 26227 PHGDH PGDH3 Brain lower grade glioma Phosphorylation N T89 O43175 26227 PHGDH PGDH3 Uterine corpus endometrial carcinoma Phosphorylation N T89 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Phosphorylation N T125 O43175 26227 PHGDH PGDH3 Seizures Phosphorylation N T125 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Phosphorylation N S127 O43175 26227 PHGDH PGDH3 Seizures Phosphorylation N S127 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K129 O43175 26227 PHGDH PGDH3 Seizures Ubiquitination N K129 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Acetylation N K132 O43175 26227 PHGDH PGDH3 Neu-Laxova syndrome Acetylation N K137 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Acetylation N K137 O43175 26227 PHGDH PGDH3 Hepatocellular carcinoma Ubiquitination N K137 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K137 O43175 26227 PHGDH PGDH3 Neu-Laxova syndrome Phosphorylation N T141 O43175 26227 PHGDH PGDH3 Hepatocellular carcinoma Ubiquitination N K146 O43175 26227 PHGDH PGDH3 Hepatocellular carcinoma Phosphorylation N T147 O43175 26227 PHGDH PGDH3 Colon adenocarcinoma Methylation N R236 O43175 26227 PHGDH PGDH3 Esophageal carcinoma Methylation N R236 O43175 26227 PHGDH PGDH3 Neu-Laxova syndrome Methylation N R236 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Methylation N R236 O43175 26227 PHGDH PGDH3 Stomach adenocarcinoma Methylation N R236 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Methylation N R247 O43175 26227 PHGDH PGDH3 Stomach adenocarcinoma Methylation N R247 O43175 26227 PHGDH PGDH3 Uterine corpus endometrial carcinoma Ubiquitination N K289 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K308 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Phosphorylation C S326 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Phosphorylation N S362 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K364 O43175 26227 PHGDH PGDH3 Stomach adenocarcinoma Ubiquitination N K364 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Phosphorylation N S371 O43175 26227 PHGDH PGDH3 Stomach adenocarcinoma Phosphorylation N S371 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Ubiquitination N K380 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K380 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K380 O43175 26227 PHGDH PGDH3 Lung adenocarcinoma Ubiquitination N K384 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K384 O43175 26227 PHGDH PGDH3 Hepatocellular carcinoma Ubiquitination N K394 O43175 26227 PHGDH PGDH3 Hepatocellular carcinoma Ubiquitination N K522 O43175 26227 PHGDH PGDH3 Phosphoglycerate dehydrogenase deficiency Ubiquitination N K522 P17676 1051 CEBPB TCF5 PP9092 Hepatocellular carcinoma Ubiquitination N K315 P17676 1051 CEBPB TCF5 PP9092 Hepatocellular carcinoma Ubiquitination N K316 P29966 4082 MARCKS MACS PRKCSL Bladder urothelial carcinoma Ubiquitination N K11 P29966 4082 MARCKS MACS PRKCSL Kidney renal clear cell carcinoma Ubiquitination N K11 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S26 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S27 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S29 P29966 4082 MARCKS MACS PRKCSL Melanoma Phosphorylation N S29 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K30 P29966 4082 MARCKS MACS PRKCSL Ovarian adenocarcinoma Phosphorylation N S63 P29966 4082 MARCKS MACS PRKCSL Ovarian adenocarcinoma Ubiquitination N K69 P29966 4082 MARCKS MACS PRKCSL Colorectal cancer Phosphorylation N S118 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation N S128 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation C S131 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation N S132 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation N T133 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation N S134 P29966 4082 MARCKS MACS PRKCSL Cervical squamous cell carcinoma Phosphorylation N S135 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Methylation N K161 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Phosphorylation N S163 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Ubiquitination N K165 P29966 4082 MARCKS MACS PRKCSL Lung cancer Phosphorylation N S167 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Phosphorylation N S167 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Phosphorylation N S170 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Acetylation N K172 P29966 4082 MARCKS MACS PRKCSL Lung squamous cell carcinoma Methylation N K172 P29966 4082 MARCKS MACS PRKCSL Breast adenocarcinoma Phosphorylation N S314 P29966 4082 MARCKS MACS PRKCSL Breast cancer Phosphorylation N S314 P29966 4082 MARCKS MACS PRKCSL Stomach adenocarcinoma Phosphorylation N S314 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N T24 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N T24 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N T28 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N T28 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation C T30 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N T30 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N T30 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K41 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K41 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K92 P31040 6389 SDHA SDH2 SDHF Kidney renal papillary cell carcinoma Ubiquitination N K92 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K92 P31040 6389 SDHA SDH2 SDHF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K167 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Ubiquitination N K167 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K167 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K167 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation C S177 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Phosphorylation N S177 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S177 P31040 6389 SDHA SDH2 SDHF Lung adenocarcinoma Phosphorylation N S177 P31040 6389 SDHA SDH2 SDHF Lung squamous cell carcinoma Phosphorylation N S177 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S177 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K179 P31040 6389 SDHA SDH2 SDHF Lung adenocarcinoma Acetylation N K179 P31040 6389 SDHA SDH2 SDHF Lung squamous cell carcinoma Acetylation N K179 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K179 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K179 P31040 6389 SDHA SDH2 SDHF Lung adenocarcinoma Ubiquitination N K179 P31040 6389 SDHA SDH2 SDHF Lung squamous cell carcinoma Ubiquitination N K179 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K179 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Phosphorylation N Y215 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N Y215 P31040 6389 SDHA SDH2 SDHF Liver cancer Phosphorylation N Y215 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N Y215 P31040 6389 SDHA SDH2 SDHF Bladder urothelial carcinoma Phosphorylation N S243 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S243 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S243 P31040 6389 SDHA SDH2 SDHF Uterine corpus endometrial carcinoma Phosphorylation N S243 P31040 6389 SDHA SDH2 SDHF Bone cancer Acetylation N K250 P31040 6389 SDHA SDH2 SDHF Chondrosarcoma Acetylation N K250 P31040 6389 SDHA SDH2 SDHF Bladder urothelial carcinoma Ubiquitination N K250 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K250 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K250 P31040 6389 SDHA SDH2 SDHF Uterine corpus endometrial carcinoma Ubiquitination N K250 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation C S321 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation C S321 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S321 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S321 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K335 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K335 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K335 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K335 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K361 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K361 P31040 6389 SDHA SDH2 SDHF Uterine corpus endometrial carcinoma Acetylation N K361 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N Y365 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N Y365 P31040 6389 SDHA SDH2 SDHF Uterine corpus endometrial carcinoma Phosphorylation N Y365 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K418 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K418 P31040 6389 SDHA SDH2 SDHF Adrenocortical carcinoma Phosphorylation N Y436 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N Y436 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N Y436 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation C S456 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation C S456 P31040 6389 SDHA SDH2 SDHF Breast adenocarcinoma Phosphorylation N S456 P31040 6389 SDHA SDH2 SDHF Breast invasive carcinoma Phosphorylation N S456 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S456 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S456 P31040 6389 SDHA SDH2 SDHF Neurodegeneration Phosphorylation N S456 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K485 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K485 P31040 6389 SDHA SDH2 SDHF Bladder urothelial carcinoma Acetylation N K498 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K498 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K498 P31040 6389 SDHA SDH2 SDHF Bladder urothelial carcinoma Ubiquitination N K498 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K498 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K498 P31040 6389 SDHA SDH2 SDHF Bladder urothelial carcinoma Methylation N R500 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R500 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S505 P31040 6389 SDHA SDH2 SDHF Hepatocellular carcinoma Methylation N R507 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R507 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R507 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S509 P31040 6389 SDHA SDH2 SDHF Hepatocellular carcinoma Methylation N R512 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R512 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R512 P31040 6389 SDHA SDH2 SDHF Hepatocellular carcinoma Ubiquitination N K517 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K517 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K517 P31040 6389 SDHA SDH2 SDHF Skin cutaneous melanoma Ubiquitination N K517 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation C S530 P31040 6389 SDHA SDH2 SDHF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S530 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Phosphorylation N S530 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S530 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S530 P31040 6389 SDHA SDH2 SDHF Uterine corpus endometrial carcinoma Phosphorylation N S530 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Ubiquitination N K538 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K538 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K538 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K541 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K541 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K541 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K541 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K547 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K547 P31040 6389 SDHA SDH2 SDHF Stomach adenocarcinoma Acetylation N K547 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N K547 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N K547 P31040 6389 SDHA SDH2 SDHF Stomach adenocarcinoma Methylation N K547 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K547 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K547 P31040 6389 SDHA SDH2 SDHF Stomach adenocarcinoma Ubiquitination N K547 P31040 6389 SDHA SDH2 SDHF Dilated cardiomyopathy Acetylation N K550 P31040 6389 SDHA SDH2 SDHF Leigh syndrome Acetylation N K550 P31040 6389 SDHA SDH2 SDHF Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R585 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Methylation N R585 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R585 P31040 6389 SDHA SDH2 SDHF Lung adenocarcinoma Methylation N R585 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R585 P31040 6389 SDHA SDH2 SDHF Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N R589 P31040 6389 SDHA SDH2 SDHF Colon adenocarcinoma Methylation N R589 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R589 P31040 6389 SDHA SDH2 SDHF Lung adenocarcinoma Methylation N R589 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R589 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R594 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R594 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K608 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K608 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K608 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K608 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K616 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K616 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Acetylation N K624 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Acetylation N K624 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K624 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K624 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N S628 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N S628 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Phosphorylation N Y629 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Phosphorylation N Y629 P31040 6389 SDHA SDH2 SDHF Chromophobe renal cell carcinoma Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Kidney chromophobe Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Pheochromocytoma and Paraganglioma Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Stomach adenocarcinoma Ubiquitination N K647 P31040 6389 SDHA SDH2 SDHF Hereditary cancer-predisposing syndrome Methylation N R662 P31040 6389 SDHA SDH2 SDHF Mitochondrial complex II deficiency Methylation N R662 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Phosphorylation N Y45 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Acetylation N K49 P40763 6774 STAT3 APRF Colorectal adenocarcinoma Methylation N K49 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K87 P40763 6774 STAT3 APRF Skin cutaneous melanoma Acetylation N K87 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K87 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K87 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K97 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K153 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K153 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K161 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K161 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K163 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma SUMOylation N K177 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K177 P40763 6774 STAT3 APRF Lung adenocarcinoma SUMOylation N K177 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K177 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K177 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K177 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K180 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K180 P40763 6774 STAT3 APRF Lung adenocarcinoma Ubiquitination N K180 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K199 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Ubiquitination N K199 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K283 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K283 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K283 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K290 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K290 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Ubiquitination N K290 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K290 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K294 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K294 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K294 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K318 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K318 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K348 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K348 P40763 6774 STAT3 APRF Skin cutaneous melanoma Ubiquitination N K363 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K363 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K365 P40763 6774 STAT3 APRF Kidney renal papillary cell carcinoma Acetylation N K370 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Acetylation N K370 P40763 6774 STAT3 APRF Kidney renal papillary cell carcinoma Ubiquitination N K370 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K370 P40763 6774 STAT3 APRF hyper IgE syndrome Acetylation N K383 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K383 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K383 P40763 6774 STAT3 APRF Uterine carcinosarcoma Ubiquitination N K383 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K409 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K409 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF Breast invasive carcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S429 P40763 6774 STAT3 APRF Lung adenocarcinoma Phosphorylation N S429 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N S429 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N T440 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T440 P40763 6774 STAT3 APRF Pheochromocytoma and Paraganglioma Phosphorylation N T440 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T440 P40763 6774 STAT3 APRF Bladder urothelial carcinoma Phosphorylation N Y446 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y446 P40763 6774 STAT3 APRF Pheochromocytoma and Paraganglioma Phosphorylation N Y446 P40763 6774 STAT3 APRF Bladder urothelial carcinoma SUMOylation N K451 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K451 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome SUMOylation N K495 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y539 P40763 6774 STAT3 APRF Ovarian serous cystadenocarcinoma Phosphorylation N Y539 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K551 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K574 P40763 6774 STAT3 APRF Uterine corpus endometrial carcinoma Ubiquitination N K574 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K601 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K601 P40763 6774 STAT3 APRF Breast invasive carcinoma Acetylation N K615 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K615 P40763 6774 STAT3 APRF Hematologic cancer Acetylation N K615 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K615 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Acetylation N K615 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Acetylation N K615 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Acetylation N K615 P40763 6774 STAT3 APRF Prostate adenocarcinoma Acetylation N K615 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K615 P40763 6774 STAT3 APRF Lung squamous cell carcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K615 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K615 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K615 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K615 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T622 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K626 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K626 P40763 6774 STAT3 APRF Breast invasive carcinoma Acetylation N K631 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K631 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K631 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K631 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T632 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N S636 P40763 6774 STAT3 APRF Breast invasive carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Glioblastoma multiforme Phosphorylation N Y640 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y640 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N Y640 P40763 6774 STAT3 APRF Prostate adenocarcinoma Phosphorylation N Y640 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N Y640 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T641 P40763 6774 STAT3 APRF hyper IgE syndrome Phosphorylation N T641 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Ubiquitination N K642 P40763 6774 STAT3 APRF Breast invasive carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Glioblastoma multiforme Ubiquitination N K642 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K642 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Ubiquitination N K642 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Ubiquitination N K642 P40763 6774 STAT3 APRF Prostate adenocarcinoma Ubiquitination N K642 P40763 6774 STAT3 APRF hyper IgE syndrome Ubiquitination N K642 P40763 6774 STAT3 APRF Breast adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y657 P40763 6774 STAT3 APRF Lymphoid neoplasm diffuse large B-cell lymphoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Stomach adenocarcinoma Phosphorylation N Y657 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y674 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N Y674 P40763 6774 STAT3 APRF Prostate adenocarcinoma Phosphorylation N Y674 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K679 P40763 6774 STAT3 APRF Hepatocellular carcinoma Acetylation N K685 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K685 P40763 6774 STAT3 APRF Hepatocellular carcinoma Ubiquitination N K685 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K685 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N Y686 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y686 P40763 6774 STAT3 APRF Hepatocellular carcinoma Phosphorylation N S691 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S691 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S701 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N S701 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N Y705 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N Y705 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Acetylation N K707 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Acetylation N K707 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Ubiquitination N K707 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Ubiquitination N K707 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T708 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N T708 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation C T714 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T714 P40763 6774 STAT3 APRF Inherited immunodeficiency diseases Phosphorylation N T714 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T716 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T717 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N T717 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N S719 P40763 6774 STAT3 APRF Hyper-IgE recurrent infection syndrome Phosphorylation N S719 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N S719 P40763 6774 STAT3 APRF Autoimmune disease, multisystem, infantile-onset Phosphorylation N T721 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N T721 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N T721 P40763 6774 STAT3 APRF Kidney renal clear cell carcinoma Phosphorylation N S727 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Phosphorylation N S727 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Brain lower grade glioma Phosphorylation N S46 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast invasive carcinoma Phosphorylation N S46 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Hepatocellular carcinoma Phosphorylation N S46 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Non-Hodgkin's lymphoma Phosphorylation N S46 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Brain lower grade glioma Ubiquitination N K53 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast invasive carcinoma Ubiquitination N K53 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Non-Hodgkin's lymphoma Ubiquitination N K53 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Non-Hodgkin's lymphoma Phosphorylation N S58 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast adenocarcinoma Ubiquitination N K77 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Ubiquitination N K77 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Head and neck squamous cell carcinoma Phosphorylation N S161 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Uterine cancer Phosphorylation N S161 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Head and neck squamous cell carcinoma Phosphorylation N S166 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Head and neck squamous cell carcinoma Phosphorylation N S167 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Uterine carcinosarcoma Phosphorylation N S189 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Bladder urothelial carcinoma Phosphorylation N S197 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Rectum adenocarcinoma Phosphorylation N S197 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Uterine carcinosarcoma Phosphorylation N S197 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Bladder urothelial carcinoma Phosphorylation N T203 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Rectum adenocarcinoma Phosphorylation N T203 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Rectum adenocarcinoma Phosphorylation C S204 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Bladder urothelial carcinoma Phosphorylation N S204 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K221 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Ubiquitination N K221 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K225 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Hepatocellular carcinoma SUMOylation N K225 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma SUMOylation N K225 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Hepatocellular carcinoma Ubiquitination N K231 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast invasive carcinoma Phosphorylation N T266 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Hepatocellular carcinoma Phosphorylation N T266 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Sarcoma Ubiquitination N K297 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Sarcoma Phosphorylation N Y298 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Sarcoma Ubiquitination N K306 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Stomach adenocarcinoma Ubiquitination N K306 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Stomach adenocarcinoma Phosphorylation N S312 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K335 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K343 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Methylation N K344 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K344 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S345 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S347 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Malignant glioma Phosphorylation N S347 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Phosphorylation N S349 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Uterine cancer Phosphorylation N S349 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Phosphorylation C S359 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S359 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S361 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Phosphorylation N S361 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Bladder urothelial carcinoma Phosphorylation N S374 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Bladder urothelial carcinoma Ubiquitination N K386 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Glioblastoma multiforme Ubiquitination N K386 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Acetylation N K426 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Phosphorylation N T430 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung squamous cell carcinoma Ubiquitination N K445 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Pancreatic adenocarcinoma Ubiquitination N K588 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S699 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Prostate adenocarcinoma Phosphorylation N S699 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S705 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S708 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N T710 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast adenocarcinoma Phosphorylation N S716 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Liver cancer Phosphorylation N S716 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Breast adenocarcinoma Ubiquitination N K778 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K817 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Ovarian adenocarcinoma Acetylation N K817 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma SUMOylation N K826 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Hepatocellular carcinoma Ubiquitination N K843 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K885 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Head and neck squamous cell carcinoma Ubiquitination N K885 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Acetylation N K893 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cervical squamous cell carcinoma and endocervical adenocarcinoma Ubiquitination N K893 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Kidney renal papillary cell carcinoma Phosphorylation N Y935 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Ubiquitination N K1068 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Lung adenocarcinoma Phosphorylation N S1078 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Kidney renal papillary cell carcinoma SUMOylation N K1107 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Skin cutaneous melanoma Phosphorylation N S1147 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Uterine corpus endometrial carcinoma Phosphorylation N S1468 P40763 6774 STAT3 APRF Pancreatic cancer tumor tissue Phosphorylation U 37443111 P40763 6774 STAT3 APRF Non-small cell lung cancer tumor tissue Deubiquitination U 30881015 P40763 6774 STAT3 APRF Hepatocellular carcinoma HCC tissues Acetylation U 37792308 P40763 6774 STAT3 APRF Oral squamous cell carcinoma tumor tissue Phosphorylation U 35562900 P40763 6774 STAT3 APRF Triple-negative breast cancer tumor tissue Phosphorylation U 37095176 P40763 6774 STAT3 APRF Gastric cancer tumor tissue Phosphorylation U 36769245 P40763 6774 STAT3 APRF Psoriasis epidermal keratinocytes Phosphorylation U 28901004 P40763 6774 STAT3 APRF Triple-negative breast cancer tumor tissue Phosphorylation U 34408002 P40763 6774 STAT3 APRF Colorectal cancer tumor tissue Phosphorylation U 33982216 P40763 6774 STAT3 APRF Pancreatic cancer tumor tissue Deubiquitination U 33123271 P40763 6774 STAT3 APRF Retinoblastoma tumor tissue Ubiquitination P 35980647 O43175 26227 PHGDH PGDH3 Breast cancer breast cancer tissues Ubiquitination D 32783943 P40763 6774 STAT3 APRF Breast cancer tumor tissue Deacetylation D 30365149 P40763 6774 STAT3 APRF Renal cell carcinoma RCC tissues Deacetylation A 31201813 O43175 26227 PHGDH PGDH3 Cancer tumor tissue Serine phosphorylation P S55 34663976 O43175 26227 PHGDH PGDH3 Breast cancer breast cancer tissue Acetylation P K58 32783943 O43175 26227 PHGDH PGDH3 Breast cancer breast cancer tissue Deacetylation A K58 32783943 O43175 26227 PHGDH PGDH3 Cancer tumor tissue Serine phosphorylation P S371 34663976 P17676 1051 CEBPB TCF5 PP9092 Alcoholic liver disease liver tissues Deacetylation A K102 34642310 P17676 1051 CEBPB TCF5 PP9092 Alcoholic liver disease liver tissues Deacetylation A K211 34642310 P29966 4082 MARCKS MACS PRKCSL Heart failure cardiac myocytes N-myristoylation D G2 38094695 P29966 4082 MARCKS MACS PRKCSL Neural tube defect neural tissues Acetylation P K165 30655546 P29966 4082 MARCKS MACS PRKCSL Neural tube defect neural tissues Deacetylation A K165 30655546 P31040 6389 SDHA SDH2 SDHF Cancer tumor tissue Deacetylation A K335 32694775 P31040 6389 SDHA SDH2 SDHF Clear cell renal cell carcinoma ccRCC tissues Desuccinylation P K547 30703481 P40763 6774 STAT3 APRF Glioblastoma tumor tissue Lysine methylation U K180 29076964 P40763 6774 STAT3 APRF Prostate cancer tumor tissue Threonine phosphorylation D T622 35722967 P40763 6774 STAT3 APRF Triple-negative breast cancer breast tumor tissues Lysine methylation U K685 29487338 P40763 6774 STAT3 APRF Colorectal cancer tumor tissue Tyrosine phosphorylation U Y705 36266267 P40763 6774 STAT3 APRF Glioblastoma glioblastoma tissue Tyrosine phosphorylation U Y705 34411567;20455003 P40763 6774 STAT3 APRF Melanoma tumor tissue Tyrosine phosphorylation U Y705 35184394;22899991 P40763 6774 STAT3 APRF Multiple myeloma tumor tissue Tyrosine phosphorylation U Y705 34782371 P40763 6774 STAT3 APRF Pancreatic cancer pancreatic cancer cells Tyrosine phosphorylation U Y705 37548811;36374556 P40763 6774 STAT3 APRF Triple-negative breast cancer breast tumor tissues Tyrosine phosphorylation U Y705 34066153;35091679 P40763 6774 STAT3 APRF Breast cancer BRCA tissues Dimethylation U R729 37813837 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cancer tumor tissue Acetylation P K426 32518374 Q9UIG0 9031 BAZ1B WBSC10 WBSCR10 WBSCR9 WSTF Cancer tumor tissue Deacetylation A K426 32518374 P40763 6774 STAT3 APRF Chronic lymphocytic leukemia Acetylation U K685 30263097 P40763 6774 STAT3 APRF B-cell acute lymphoblastic leukemia Serine phosphorylation U S727 33393494 P40763 6774 STAT3 APRF Small cell lung cancer/carcinoma tumor tissue Phosphorylation U 22938476 P40763 6774 STAT3 APRF Precancerous lesion of gastric cancer tumor tissue Phosphorylation U 23596790 P40763 6774 STAT3 APRF Colon cancer/carcinoma tumor tissue Phosphorylation P 23335526 P40763 6774 STAT3 APRF Liver cancer tumor tissue Phosphorylation P 23460367 P40763 6774 STAT3 APRF Ulcerative colitis colonic tissues Palmitoylation U 38150914 P40763 6774 STAT3 APRF Osteosarcoma OS cells Phosphorylation U 32549792 P40763 6774 STAT3 APRF Hepatocellular carcinoma tumor tissue Phosphorylation U 37178251 P40763 6774 STAT3 APRF Gastric cancer SGC-7901 Phosphorylation U 35087591 P40763 6774 STAT3 APRF Non-small cell lung cancer TAM/M2 Phosphorylation U 36372977 P40763 6774 STAT3 APRF Cancer tumor tissue Acetylation A K685 38000524 P40763 6774 STAT3 APRF Bladder cancer bladder cancer tissues Phosphorylation U Y705 34326684 P40763 6774 STAT3 APRF Bladder cancer bladder cancer cells Tyrosine phosphorylation N Y705 18939995 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma breast cancer cell lines Tyrosine phosphorylation P Y705 23350355;22374428;23446809 P40763 6774 STAT3 APRF Colon cancer/carcinoma CRC cells Tyrosine phosphorylation P Y705 22754353;21840932 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma tumor tissue Tyrosine phosphorylation U Y705 24707243 P40763 6774 STAT3 APRF Cancer cell line Tyrosine phosphorylation U Y705 23145121 P40763 6774 STAT3 APRF Colon adenocarcinoma COAD tissues Tyrosine phosphorylation U Y705 34270850 P40763 6774 STAT3 APRF Esophageal squamous cell carcinoma ESCC cell lines Tyrosine phosphorylation U Y705 23676499 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma pancreatic cancer cells Tyrosine phosphorylation U Y705 18519681 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma tumor tissue Tyrosine phosphorylation U Y705 22307624;19147545 P40763 6774 STAT3 APRF Renal cancer/carcinoma renal carcinoma Caki cells Tyrosine phosphorylation U Y705 22982675 P40763 6774 STAT3 APRF Renal cell carcinoma cell line Tyrosine phosphorylation U Y705 22899991 P40763 6774 STAT3 APRF Pancreatic cancer pancreatic cancer cells Serine phosphorylation D S727 37548811 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma cell lines Serine phosphorylation D S727 18519681 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma cell line Serine phosphorylation P S727 23329648;23329839 P40763 6774 STAT3 APRF Cancer cell line Serine phosphorylation P S727 23145121 P40763 6774 STAT3 APRF Melanoma melanoma cells Serine phosphorylation P S727 22418867 P40763 6774 STAT3 APRF Hepatocellular carcinoma HCC cells Serine phosphorylation U S727 31498440 P40763 6774 STAT3 APRF Thyroid cancer/carcinoma tumor tissue Serine phosphorylation U S727 17209045 P40763 6774 STAT3 APRF Neuroblastoma Phosphorylation U 15715521 P40763 6774 STAT3 APRF Bladder cancer Phosphorylation U 15034568 P40763 6774 STAT3 APRF Glioblastoma Phosphorylation C 24135280 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma Phosphorylation U 10853013 P40763 6774 STAT3 APRF Breast cancer/tumor/carcinoma Phosphorylation U 10853013 P40763 6774 STAT3 APRF Ulcerative colitis Phosphorylation U 11181699 P40763 6774 STAT3 APRF Crohn's disease Phosphorylation U 11181699 P40763 6774 STAT3 APRF Colitis Phosphorylation U 11181699 P40763 6774 STAT3 APRF Bladder cancer Phosphorylation U 23526079 P40763 6774 STAT3 APRF Gastric cancer Phosphorylation U 24116074 P40763 6774 STAT3 APRF Endometrial cancer/carcinoma Phosphorylation U 24321270 P40763 6774 STAT3 APRF Pancreatic cancer/carcinoma/adenocarcinoma Phosphorylation P 24132924 P40763 6774 STAT3 APRF Skin cancer Phosphorylation P 24460316 P29966 4082 MARCKS MACS PRKCSL Glioma Phosphorylation P 8455032 P29966 4082 MARCKS MACS PRKCSL B-cell chronic lymphocytic leukemia Phosphorylation P 8596017 P40763 6774 STAT3 APRF Ovarian cancer/carcinoma Phosphorylation P 15010843 P40763 6774 STAT3 APRF Sarcoma Phosphorylation P 15010843 P17676 1051 CEBPB TCF5 PP9092 Cardiac hypertrophy SUMOylation U K134 35002525 P29966 4082 MARCKS MACS PRKCSL Alzheimer's disease Serine phosphorylation U S46 27557632 P29966 4082 MARCKS MACS PRKCSL Alzheimer's disease Serine phosphorylation U S132 27557632 P29966 4082 MARCKS MACS PRKCSL Alzheimer's disease Serine phosphorylation U S147 27557632 P29966 4082 MARCKS MACS PRKCSL Alzheimer's disease Threonine phosphorylation U T150 27557632 P31040 6389 SDHA SDH2 SDHF Cardiomyopathy Acetylation U K179 26998524 P40763 6774 STAT3 APRF Glioblastoma Lysine methylation P K180 23684459 P40763 6774 STAT3 APRF Chronic myelogenous leukemia/chronic myeloid leukemia Phosphorylation N Y640 23872306 P40763 6774 STAT3 APRF Lymphoma Acetylation U K685 27582487 P40763 6774 STAT3 APRF Prostate cancer Acetylation U K685 28489571 P40763 6774 STAT3 APRF Triple-negative breast cancer Acetylation U K685 29137356 P40763 6774 STAT3 APRF Nasopharyngeal carcinoma Dephosphorylation U Y705 33824475 P40763 6774 STAT3 APRF Inflammatory disease Tyrosine phosphorylation D Y705 24063605 P40763 6774 STAT3 APRF Triple-negative breast cancer Tyrosine phosphorylation D Y705 36017196 P40763 6774 STAT3 APRF Acute myelogenous leukemia Tyrosine phosphorylation U Y705 34525179 P40763 6774 STAT3 APRF B-cell lymphoma Tyrosine phosphorylation U Y705 22116549 P40763 6774 STAT3 APRF Breast cancer Tyrosine phosphorylation U Y705 17967179;17967179;18353781;35927628 P40763 6774 STAT3 APRF Clear cell kidney cancer Tyrosine phosphorylation U Y705 24615012 P40763 6774 STAT3 APRF Esophageal carcinoma Tyrosine phosphorylation U Y705 33986510 P40763 6774 STAT3 APRF Experimental autoimmune encephalomyelitis Tyrosine phosphorylation U Y705 32094172 P40763 6774 STAT3 APRF Fibrosarcoma Tyrosine phosphorylation U Y705 21575192 P40763 6774 STAT3 APRF Glioblastoma multiforme Tyrosine phosphorylation U Y705 35670018 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Tyrosine phosphorylation U Y705 21281788 P40763 6774 STAT3 APRF Hepatocellular carcinoma Tyrosine phosphorylation U Y705 22153071 P40763 6774 STAT3 APRF Hepatocellular carcinoma/hepatocarcinoma/hepatoma Tyrosine phosphorylation U Y705 21311975 P40763 6774 STAT3 APRF Laryngeal cancer Tyrosine phosphorylation U Y705 27181202 P40763 6774 STAT3 APRF Lung cancer Tyrosine phosphorylation U Y705 34543857 P40763 6774 STAT3 APRF Malignant gliomas Tyrosine phosphorylation U Y705 23740516 P40763 6774 STAT3 APRF Multiple sclerosis Tyrosine phosphorylation U Y705 32094172 P40763 6774 STAT3 APRF Myeloma Tyrosine phosphorylation U Y705 22210382 P40763 6774 STAT3 APRF Neurofibromatosis Tyrosine phosphorylation U Y705 23318430 P40763 6774 STAT3 APRF Non-Hodgkin's lymphoma Tyrosine phosphorylation U Y705 30054295 P40763 6774 STAT3 APRF Prostate cancer Tyrosine phosphorylation U Y705 19147545;19147545 P40763 6774 STAT3 APRF T-cell lymphoma Tyrosine phosphorylation U Y705 35882439 P40763 6774 STAT3 APRF Clear cell kidney cancer Threonine phosphorylation U T714 24615012 P40763 6774 STAT3 APRF Oral squamous epithelial carcinoma Serine phosphorylation D S727 23733313 P40763 6774 STAT3 APRF Triple-negative breast cancer Serine phosphorylation D S727 36017196 P40763 6774 STAT3 APRF Prostate cancer/carcinoma/adenocarcinoma Serine phosphorylation P S727 23941877 P40763 6774 STAT3 APRF Chronic lymphocytic leukemia Serine phosphorylation U S727 35595309 P40763 6774 STAT3 APRF Clear cell kidney cancer Serine phosphorylation U S727 24615012;33772065;37945711 P40763 6774 STAT3 APRF Glioblastoma multiforme Serine phosphorylation U S727 35670018 P40763 6774 STAT3 APRF Head and neck squamous cell carcinoma Serine phosphorylation U S727 21281788 P40763 6774 STAT3 APRF Prostate cancer Serine phosphorylation U S727 18829527